Sign In

Flavia Nery

Clinical Development, Neurodegenerative Disorders

Flavia Nery is a Medical Director at Biogen, where she focuses on clinical development, particularly in the field of neuroscience. Her recent work includes presenting data on BIIB113, an O-GlcNAcase inhibitor aimed at treating tauopathies, during the AD/PD conference in March 2024. This compound has shown promising results in early trials, demonstrating significant engagement with its target in the brain and a favorable safety profile.1

In addition to her role at Biogen, Nery has an academic background as an Assistant in Neuroscience at Massachusetts General Hospital and serves as an Instructor of Neurology at Harvard University. Her research primarily revolves around genetic factors related to neurodegenerative diseases.23 Before her current position, she held various roles at Biogen Idec and Massachusetts General Hospital, contributing to her extensive experience in clinical science and project management.34

Nery's educational qualifications include a postdoctoral degree from Harvard Medical School, which underlines her expertise in the field.5

Highlights

Mar 1 · linkedin

I am speaking at AD/PD 2024. Please check out our talk if you're attending this conference! #BIIB113 FIH results #biogen

Mar 24 · linkedin

Dear friends and colleagues,

I am here to ask you to take a moment to check out my GoFundMe campaign. My nephew, Victor, is still in the hospital with aspiration pneumonia. Victor was born with Congenital Myotonic Distrophy (DM1).

Doctor are planning to send Victor home with no home care. So, his parents will be on their own to take care of his medical expenses. They are in hug need of a cough assist, hospital bed, medication cover, O2 tank, and other things.

https://gofund.me/d9512aaf

Your support would mean a lot to me.

Thank you so much!

https://lnkd.in/eZpHtghh

Related Questions

What are Flavia Nery's main responsibilities as Medical Director at Biogen?
What is the significance of the OGA inhibitor BIIB113 in tauopathies research?
How does Flavia Nery's work at Biogen contribute to the understanding of tauopathies?
What are the key findings from the Phase 1 trial of BIIB113?
What other projects is Flavia Nery currently involved in at Biogen?
Flavia Nery
Flavia Nery, photo 1
Flavia Nery, photo 2
Add to my network

Location

Greater Boston